Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01472159 · ClinicalTrials.gov registry record · NA

Can Glucose Monitoring Improve (CGMi Study)

A NA study of Type 1 Diabetes, sponsored by Joslin Diabetes Center.

Completed
Registry status
NA
Development phase
130
Enrollment target
1
Study location

NCT01472159 is a NA study of Type 1 Diabetes that has completed, run by Joslin Diabetes Center. The registered enrollment target is 130 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01472159, a NA study of Type 1 Diabetes, has completed, sponsored by Joslin Diabetes Center.

COMPLETED
Registry status
NA
Development phase
130 participants
Enrollment target
1
Study location

Study Summary

The purpose of this 2-year randomized controlled trial (RCT) is to implement and evaluate a family-focused behavioral teamwork intervention aimed at overcoming barriers to sustained continuous glucose monitoring (CGM) use in youth with type 1 diabetes (T1D). We hypothesize that CGM implemented with a family-focused, behavioral teamwork intervention will result in sustained CGM use and greater improvement in A1c compared to routine implementation of CGM.

Conditions Studied

Interventions

  • BEHAVIORAL CGM Family Teamwork Intervention

Study Locations (1)

Massachusetts

  • Joslin Diabetes Center - Boston

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2011-10
Est. Completion 2015-08
Phase NA

Sponsor

Joslin Diabetes Center

73 total trials

What the Registry Record Tells You About NCT01472159

The ClinicalTrials.gov registry entry for NCT01472159 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (84% lower). The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which CGM Family Teamwork Intervention is the first listed.

NCT01472159 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01472159 about?

NCT01472159 is a clinical study titled "Can Glucose Monitoring Improve (CGMi Study)". The purpose of this 2-year randomized controlled trial (RCT) is to implement and evaluate a family-focused behavioral teamwork intervention aimed at overcoming barriers to sustained continuous glucose monitoring (CGM) use in youth with type 1 diabetes (T1D). We hypothesize that CGM implemented with ...

What is the current status of trial NCT01472159?

This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2011-10. Estimated completion is 2015-08.

What conditions does trial NCT01472159 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

What interventions are being tested in trial NCT01472159?

The interventions under investigation include: CGM Family Teamwork Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01472159?

This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01472159 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.